also at musicfeeds: some nice walkin' -around money for up 'n' comers
Sydney’s Good Intent Offers Emerging Artists $25K Career Boost
Designed to provide a launchpad for exceptional emerging artists to kickstart their career, the Greater Good Initiative is open to all independent Australian artists. Applications are open now, and will close on Thursday, 28th September at 5PM AEST.

#music #oz #moneh

Sydney Agency Good Intent Offers Emerging Artists $25K Career Boost

CC: independent Aussie artists

"We asked a hacker why they target us" and they told us.
ABC
I see.

#Australia #straya #moneh #fornoreason #excellent

'Australians are the most stupidest humans': We asked a hacker why they target us

A hacker — who claims to have been part of one of the world's most successful gangs — tells us why Australia is a target and laughs at the distress caused by the Medibank data breach.

"We will reach a time when the Congolese children of this generation will be saying that every foreigner, everyone around them, has looted their lives."
green energy costs a lot more than money.

https://www.abc.net.au/news/2022-02-24/cobalt-mining-in-the-congo-green-energy/100802588
https://fusecobalt.com/cobalt/cobalt-green-energy/

#cobalt #mining #moneh #child-labour #poverty #blood4batteries #Apple #Tesla #srs-rethink #green-energy

In the Congo, the brutal cost of the world's green energy future

One of the poorest countries on Earth is paying a heavy price for the world's green energy revolution.

"meme-stock mania" OUR TIME IS HERE!
https://investorplace.com/2021/07/promising-covid-19-treatment-makes-atos-stock-intriguing/

"Atossa Therapeutics mainly focuses on two diseases: breast cancer and Covid-19." Boobies and the rona - guess the cheerier workplace.
"In particular, it targets the millions of underserved people who have already contracted the virus." yess. excellent.

#sciencing-again #meme-stonk #moneh #drugs-maan #bosoms #breathing .

Promising Covid-19 Treatment Makes Atossa Therapeutics Intriguing

Traders will continue to analyze the short-squeeze potential of ATOS stock, but investors should also focus on Atossa's clinical progress.